INHIBITORS OF HUMAN TUMOR-EXPRESSED CCXCKR2
Pharmaceutical compositions containing organic compounds of formula (I) or salts thereof that serve as modulators for the SDF-1 or I-TAC chemokines are disclosed. The compounds and compositions are useful in the treatment of cancer, especially in the inhibition of cancer proliferation, growth, and m...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MELIKIAN, ANITA WRIGHT, JOHN J SCHALL, THOMAS BURNS, JENNIFER MCMASTER, BRIAN E |
| description | Pharmaceutical compositions containing organic compounds of formula (I) or salts thereof that serve as modulators for the SDF-1 or I-TAC chemokines are disclosed. The compounds and compositions are useful in the treatment of cancer, especially in the inhibition of cancer proliferation, growth, and metastasis. Methods of interfering with SDF-1 and/or I-TAC binding to the CCXCKR2 receptor and treating cancer using the compounds and pharmaceutical compositions of the present invention are also disclosed.
L'invention concerne des compositions pharmaceutiques contenant des composés organiques ou leurs sels, qui servent de modulateurs des chimiokines SDF-1 ou I-TAC. Ces composés et compositions sont utiles dans le traitement du cancer, notamment dans l'inhibition de la prolifération et de la croissance cancéreuse et de la métastéase. L'invention concerne également des procédés d'interférence avec la liaison de SDF-1 et/ou I-TAC au récepteur CCXCKR2 et le traitement du cancer à l'aide des composés et compositions pharmaceutiques de la présente invention. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2511242C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2511242C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2511242C3</originalsourceid><addsrcrecordid>eNrjZND29PPwdPIM8Q8KVvB3U_AI9XX0UwgJ9fUP0nWNCAhyDQ52dVFwdo5w9g4y4mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8c6ORqaGhkYmRs7GhFUAAPBmJAo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INHIBITORS OF HUMAN TUMOR-EXPRESSED CCXCKR2</title><source>esp@cenet</source><creator>MELIKIAN, ANITA ; WRIGHT, JOHN J ; SCHALL, THOMAS ; BURNS, JENNIFER ; MCMASTER, BRIAN E</creator><creatorcontrib>MELIKIAN, ANITA ; WRIGHT, JOHN J ; SCHALL, THOMAS ; BURNS, JENNIFER ; MCMASTER, BRIAN E</creatorcontrib><description>Pharmaceutical compositions containing organic compounds of formula (I) or salts thereof that serve as modulators for the SDF-1 or I-TAC chemokines are disclosed. The compounds and compositions are useful in the treatment of cancer, especially in the inhibition of cancer proliferation, growth, and metastasis. Methods of interfering with SDF-1 and/or I-TAC binding to the CCXCKR2 receptor and treating cancer using the compounds and pharmaceutical compositions of the present invention are also disclosed.
L'invention concerne des compositions pharmaceutiques contenant des composés organiques ou leurs sels, qui servent de modulateurs des chimiokines SDF-1 ou I-TAC. Ces composés et compositions sont utiles dans le traitement du cancer, notamment dans l'inhibition de la prolifération et de la croissance cancéreuse et de la métastéase. L'invention concerne également des procédés d'interférence avec la liaison de SDF-1 et/ou I-TAC au récepteur CCXCKR2 et le traitement du cancer à l'aide des composés et compositions pharmaceutiques de la présente invention.</description><language>eng ; fre</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100112&DB=EPODOC&CC=CA&NR=2511242C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100112&DB=EPODOC&CC=CA&NR=2511242C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MELIKIAN, ANITA</creatorcontrib><creatorcontrib>WRIGHT, JOHN J</creatorcontrib><creatorcontrib>SCHALL, THOMAS</creatorcontrib><creatorcontrib>BURNS, JENNIFER</creatorcontrib><creatorcontrib>MCMASTER, BRIAN E</creatorcontrib><title>INHIBITORS OF HUMAN TUMOR-EXPRESSED CCXCKR2</title><description>Pharmaceutical compositions containing organic compounds of formula (I) or salts thereof that serve as modulators for the SDF-1 or I-TAC chemokines are disclosed. The compounds and compositions are useful in the treatment of cancer, especially in the inhibition of cancer proliferation, growth, and metastasis. Methods of interfering with SDF-1 and/or I-TAC binding to the CCXCKR2 receptor and treating cancer using the compounds and pharmaceutical compositions of the present invention are also disclosed.
L'invention concerne des compositions pharmaceutiques contenant des composés organiques ou leurs sels, qui servent de modulateurs des chimiokines SDF-1 ou I-TAC. Ces composés et compositions sont utiles dans le traitement du cancer, notamment dans l'inhibition de la prolifération et de la croissance cancéreuse et de la métastéase. L'invention concerne également des procédés d'interférence avec la liaison de SDF-1 et/ou I-TAC au récepteur CCXCKR2 et le traitement du cancer à l'aide des composés et compositions pharmaceutiques de la présente invention.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZND29PPwdPIM8Q8KVvB3U_AI9XX0UwgJ9fUP0nWNCAhyDQ52dVFwdo5w9g4y4mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8c6ORqaGhkYmRs7GhFUAAPBmJAo</recordid><startdate>20100112</startdate><enddate>20100112</enddate><creator>MELIKIAN, ANITA</creator><creator>WRIGHT, JOHN J</creator><creator>SCHALL, THOMAS</creator><creator>BURNS, JENNIFER</creator><creator>MCMASTER, BRIAN E</creator><scope>EVB</scope></search><sort><creationdate>20100112</creationdate><title>INHIBITORS OF HUMAN TUMOR-EXPRESSED CCXCKR2</title><author>MELIKIAN, ANITA ; WRIGHT, JOHN J ; SCHALL, THOMAS ; BURNS, JENNIFER ; MCMASTER, BRIAN E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2511242C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2010</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MELIKIAN, ANITA</creatorcontrib><creatorcontrib>WRIGHT, JOHN J</creatorcontrib><creatorcontrib>SCHALL, THOMAS</creatorcontrib><creatorcontrib>BURNS, JENNIFER</creatorcontrib><creatorcontrib>MCMASTER, BRIAN E</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MELIKIAN, ANITA</au><au>WRIGHT, JOHN J</au><au>SCHALL, THOMAS</au><au>BURNS, JENNIFER</au><au>MCMASTER, BRIAN E</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INHIBITORS OF HUMAN TUMOR-EXPRESSED CCXCKR2</title><date>2010-01-12</date><risdate>2010</risdate><abstract>Pharmaceutical compositions containing organic compounds of formula (I) or salts thereof that serve as modulators for the SDF-1 or I-TAC chemokines are disclosed. The compounds and compositions are useful in the treatment of cancer, especially in the inhibition of cancer proliferation, growth, and metastasis. Methods of interfering with SDF-1 and/or I-TAC binding to the CCXCKR2 receptor and treating cancer using the compounds and pharmaceutical compositions of the present invention are also disclosed.
L'invention concerne des compositions pharmaceutiques contenant des composés organiques ou leurs sels, qui servent de modulateurs des chimiokines SDF-1 ou I-TAC. Ces composés et compositions sont utiles dans le traitement du cancer, notamment dans l'inhibition de la prolifération et de la croissance cancéreuse et de la métastéase. L'invention concerne également des procédés d'interférence avec la liaison de SDF-1 et/ou I-TAC au récepteur CCXCKR2 et le traitement du cancer à l'aide des composés et compositions pharmaceutiques de la présente invention.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA2511242C |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | INHIBITORS OF HUMAN TUMOR-EXPRESSED CCXCKR2 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T07%3A13%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MELIKIAN,%20ANITA&rft.date=2010-01-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2511242C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |